Hedge Fund Boss Odey Says Pound Could Fall Further as Brexit Deadline Looms (Reuters)
LONDON (Reuters) – Sterling and UK government bonds will fall further in the run-up to Brexit, even after the pound slumped this week to its lowest in almost a year, prominent Brexit-supporting British hedge fund manager Crispin Odey said on Thursday. While most analysts and investors still expect Britain to secure a trade deal with the EU, Odey said he was continuing to bet against the pound, a stance that could reinforce the view of some that sterling risks a rapid depreciation as the deadline for an agreement approaches.
Hedge Fund Backed by Industry Leaders Closes Its Doors (The Wall Street Journal)
A hedge fund backed by some of the industry’s biggest names, Cerrano Capital LLC, is closing less than a year after it got off the ground, the latest sign of the difficulties new funds are having raising money. Michael Weinberger’s $230 million hedge fund was launched last year, hoping to raise as much as $1 billion. The fund’s early investors included York Capital Management founder James Dinan and chief investment officer Daniel Schwartz. Billionaire hedge-fund investor Dan Loeb of Third Point LLC was among the investors…
Pressmaster/Shutterstock.com
Insider Buying: WideOpenWest Inc (WOW) Director Acquires 115,600 Shares of Stock (WeekHerald.com)
WideOpenWest Inc (NYSE:WOW) Director Crestview Partners III GP, L.P purchased 115,600 shares of the firm’s stock in a transaction on Monday, August 6th. The shares were acquired at an average cost of $10.92 per share, for a total transaction of $1,262,352.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission.
Insider Buying: Constellation Pharmaceuticals Inc (NASDAQ:CNST) Director Acquires 133,334 Shares of Stock (FairFieldcurrent.com)
Constellation Pharmaceuticals Inc (NASDAQ:CNST) Director Anthony B. Evnin bought 133,334 shares of the stock in a transaction on Monday, July 23rd. The shares were purchased at an average price of $15.00 per share, with a total value of $2,000,010.00. The transaction was disclosed in a document filed with the SEC.
Insider Buying: Caesars Entertainment Co. Common Stock (CZR) Insider Buys $955,000.00 in Stock (XNewsPress.com)
Caesars Entertainment Co. Common Stock (NASDAQ:CZR) insider Mark P. Frissora purchased 100,000 shares of the company’s stock in a transaction that occurred on Friday, August 3rd. The shares were purchased at an average price of $9.55 per share, for a total transaction of $955,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Insider Selling: AptarGroup, Inc. (NYSE:ATR) Director Sells 25,000 Shares of Stock (FairFieldCurrent.com)
AptarGroup, Inc. (NYSE:ATR) Director Stephen J. Hagge sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 31st. The stock was sold at an average price of $102.33, for a total value of $2,558,250.00. Following the transaction, the director now directly owns 110,105 shares in the company, valued at $11,267,044.65. The transaction was disclosed in a legal filing with the SEC.
Insider Selling: Thermo Fisher Scientific Inc. (TMO) CEO Sells 50,000 Shares of Stock (WeekHerald.com)
Thermo Fisher Scientific Inc. (NYSE:TMO) CEO Marc N. Casper sold 50,000 shares of the stock in a transaction on Monday, August 6th. The shares were sold at an average price of $233.95, for a total value of $11,697,500.00. Following the completion of the sale, the chief executive officer now owns 320,122 shares in the company, valued at approximately $74,892,541.90. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Insider Buying: Esperion Therapeutics Inc (ESPR) Major Shareholder Buys $2,307,000.00 in Stock (MaconDaily.com)
Esperion Therapeutics Inc (NASDAQ:ESPR) major shareholder Target N. V. Biotech purchased 50,000 shares of the stock in a transaction dated Friday, August 3rd. The stock was purchased at an average cost of $46.14 per share, for a total transaction of $2,307,000.00. Following the completion of the acquisition, the insider now owns 3,282,964 shares of the company’s stock, valued at approximately $151,475,958.96. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Insider Buying: RealNetworks Inc (RNWK) Chairman Acquires $50,591.04 in Stock (XNewsPress.com)
RealNetworks Inc (NASDAQ:RNWK) Chairman Robert Glaser acquired 14,496 shares of the company’s stock in a transaction that occurred on Monday, August 6th. The shares were acquired at an average cost of $3.49 per share, with a total value of $50,591.04. The transaction was disclosed in a filing with the SEC.
